You are not just selling a practice, you may be agreeing to become an employee, and that is the piece most sellers underweight when a bigger headline number is on the table. An independent buyer typically wants the practice and your exit: a short transition, then you are done. A DSO frequently wants the practice and you, keeping you producing under an employment agreement for years, sometimes with equity tying part of your outcome to its future exit. Neither structure is wrong. But they are different lives after closing, and the choice between them is a seller’s-experience decision, not a valuation one. How each buyer prices its offer is covered separately in DSO Valuation vs Independent Buyer; this guide is about what happens to you, your clinical decisions, and your team after the wire clears. General information, not legal, tax, or financial advice; every deal differs. As of September 2026.

Selling a dental practice to a DSO compared with an independent buyer
The two buyer types differ on price, structure, and what happens after closing.

Two Purchases, One Word, Different Futures

“Selling the practice” describes two structurally different transactions that happen to share a name. Sell to an independent buyer, usually a dentist buying a first or second location, and the deal typically resembles a real estate closing with a clinical handoff attached: a defined transition period, then a clean exit. You sell an asset, you leave, and what happens to the practice afterward is someone else’s decision.

Sell to a DSO and the transaction is frequently a hybrid: an asset or equity purchase bundled with an employment agreement that keeps you in the operatory, often for multiple years, under someone else’s brand and operating standards. You are not just the seller anymore. You are also the new hire, and that second document is where the real terms of a DSO deal live, and the one sellers spend the least time reading.

This is not a case against DSOs. DPI’s broader look at how DSO consolidation is reshaping the industry lives in DSOs vs Independent Dental Practices: What Owners Need to Know; that piece covers the market-level picture. This one is narrower and more personal: once you’ve decided to sell, what does life actually look like on the other side of each path, and what should you ask before you sign.

What Actually Changes: A Seller’s-Eye Comparison

Valuation multiples get the headlines, but the questions that determine whether a seller is happy two years later are almost all about autonomy, obligation, and control. The table below lays out the dimensions worth interrogating before you sign anything, and what to ask the buyer directly about each one.

Dimension Independent Buyer, Typical Pattern DSO, Typical Pattern What to Ask
Your role after closing Transition period (often weeks to a few months), then you’re out Continued employment, often multi-year, as an associate or clinical director Is my post-close role optional, or a deal condition?
Clinical decision-making Full autonomy ends at closing; new owner decides everything going forward Often governed by group clinical protocols, case-acceptance standards, or referral policies Who approves treatment planning and case complexity thresholds after close?
Materials, labs, and supplies New owner’s choice entirely; irrelevant to seller after transition Frequently standardized to group vendor contracts and preferred labs Am I required to switch labs, materials, or supply vendors?
Scheduling and production expectations Not applicable post-transition Often tied to a minimum production or collections target in the employment agreement What happens to my compensation if I don’t hit the target, and who sets it?
Staffing decisions New owner decides; seller has no further input Hiring, firing, and compensation for existing staff may shift to group HR Do my current staff keep their roles, pay, and benefits, and who decides that?
Fee schedules and payer participation New owner’s choice Often standardized to group-negotiated payer contracts, which may differ from the practice’s current mix Will my payer participation change, and how does that affect the patients I’ve treated for years?
Deal timeline and diligence intensity Can be leaner, but financing contingency adds real closing risk Often faster to LOI, but employment-agreement negotiation adds a second, parallel negotiation track Is the purchase agreement and the employment agreement being negotiated on the same timeline, or sequentially?

None of these are universally better or worse, a seller wanting a clean break may find every “DSO” row unappealing, while one wanting continued clinical work without ownership’s administrative burden may find the same rows reassuring. The point is to make the comparison honest before the offer’s headline number does the deciding for you.

The Employment Agreement Is the Real Document

In a DSO deal, sellers instinctively focus their attorney’s time on the purchase agreement, the document that determines what they get paid. That instinct is backwards. The purchase agreement governs what happens once, at closing. The employment agreement governs what your working life looks like for years afterward, and it is frequently the less-scrutinized document of the two.

A few provisions deserve specific attention:

  • Term. How long is the commitment: a minimum term, a target, or does it auto-renew unless someone acts?
  • Compensation structure. Base salary, percentage-of-production, percentage-of-collections, or a hybrid. Each behaves differently if patient volume or payer mix shifts after close.
  • Production expectations. Is there a floor tied to continued full payment, or to any part of the purchase consideration?
  • Termination provisions. What triggers “for cause” termination, and what happens to unpaid consideration, holdback, earnout, or unvested equity, if you’re terminated, or resign, before the term ends?
  • Early-departure consequences. The provision sellers most often skip and most often regret. If you leave before the term is up, for any reason, does any portion of the purchase price get clawed back? Does unvested equity rollover simply evaporate?

Sellers routinely negotiate hard on price and then sign the employment agreement with comparatively light review, because by that point the deal feels emotionally done. Reversing that order, treating the employment agreement with the same scrutiny, ideally reviewed by the same healthcare-transaction attorney, is the single highest-leverage habit a DSO-track seller can adopt.

Illustrative DPI editorial model, not a benchmark. The figures below are round, hypothetical numbers showing how a clawback provision can interact with an early departure, not a sourced statistic, and not typical terms.

Take a hypothetical seller who receives $1,200,000 at closing: $900,000 cash and $300,000 in equity rollover, with a four-year employment term attached. If that seller departs in year two, for reasons as ordinary as relocating for a spouse’s job, and the agreement ties the rollover’s vesting to completing the full term, the unvested $300,000 may not be paid at all. The purchase agreement’s $1,200,000 headline and the seller’s actual realized outcome can diverge sharply, governed entirely by employment-agreement language most sellers read once.

Non-Competes: Read the Scope Before the Number

Both independent and DSO deals can include a non-compete, but they carry very different weight. An independent buyer’s non-compete typically protects the goodwill they just paid for and applies once, at the sale. A DSO’s non-compete often layers on top of the employment relationship itself, meaning it can restrict where you practice after you leave the DSO’s employment, not only after you sell.

Three variables determine how much a non-compete actually constrains you: geographic scope, duration (terms vary widely by agreement), and what counts as competing, any dental practice, or a defined specialty. Enforceability also varies meaningfully by state, and the regulatory landscape around employee non-competes specifically has been in flux at the federal level in recent years. Do not rely on a general understanding of non-compete law when reviewing your own agreement, have a healthcare-transaction attorney confirm current enforceability in your state and current federal posture before you sign. DPI covers state-by-state non-compete variation in more depth in Dental Non-Compete Enforceability by State.

Equity Rollover Is a Second, Undiversified Bet

Some DSO offers include equity rollover, taking part of your consideration in equity in the DSO itself, or its holding entity, rather than cash, on the premise that the DSO will eventually sell or recapitalize at a higher valuation and your rolled equity appreciates alongside it. The pitch is straightforward: you already believe in this DSO enough to sell to it, so why not participate in its next chapter.

The risk is just as straightforward: rolled equity is illiquid, its eventual value depends on a future transaction you don’t control or time, and it concentrates your financial outcome in the same industry, often the same company, you just spent your career building income from. A seller who takes a large equity-rollover position has effectively made a second, undiversified bet on the acquirer’s future exit, on top of whatever risk they already carried as a practice owner. That may be reasonable for a seller with strong conviction in the specific DSO’s platform and management, and a poor fit for a seller who simply wants to convert decades of practice-building into liquidity. The mistake is accepting equity rollover as part of a “bigger number” without pricing in that it isn’t cash, and may never fully convert to cash on a timeline you control.

Your Staff Are Part of This Decision Too

Sellers frequently focus so heavily on their own outcome that they underweight what the sale means for the team that helped build the practice’s value in the first place, and many find they care about this more, once it’s real, than they expected going in.

An independent buyer’s plans for staff are usually straightforward to ask about directly: will current employees be retained, at current pay and roles, and for how long is that more than a verbal assurance. A DSO acquisition often introduces a second layer: benefits, PTO policy, and even job titles may shift to match the DSO’s standardized HR structure, which can be a genuine improvement (larger benefits pools, career-path options) or a genuine disruption (unfamiliar systems, a culture shift, loss of the flexibility a small practice offers), depending on the specific DSO and team. Ask for these commitments in writing where a buyer is willing to give them, and be honest about how much weight your team’s outcome carries in your own decision.

Timeline, Certainty, and Deal Fatigue

The two paths also diverge on how the deal itself unfolds, which matters more than most sellers expect going in.

An independent buyer’s deal typically carries more closing risk from financing: their offer usually depends on a lender’s underwriting, and a deal that looked settled at LOI can still die at underwriting if the buyer doesn’t clear the lender’s debt-service coverage bar. DPI’s loan pre-qualification checklist covers what a serious independent buyer should have lined up before you take their offer seriously.

A DSO deal often moves faster to signed LOI, backed by institutional capital rather than a single lender’s approval. But that speed is frequently offset by diligence intensity and a second negotiation track: the employment agreement typically runs in parallel with the purchase agreement, and DSO diligence teams are often larger and more systematic than an individual buyer’s. Whichever path you’re on, the working capital adjustment at closing applies regardless of buyer type, covered in DPI’s working capital true-up guide: and deal fatigue is real on both paths.

Questions to Ask Before You Sign

Whichever direction you’re leaning, working through a fixed sequence, in this order, before signing anything binding helps separate the decision from the momentum of an active deal.

  1. Decide what you want from the next chapter. Write down, before you’re deep in a specific deal, whether you want a clean exit or continued clinical work without ownership burden. Revisit this against any offer you receive.
  2. Ask for the employment agreement early, not late. Request a draft at the same time as the LOI, not after the purchase agreement is substantially negotiated. Reviewing it under deadline pressure is how unfavorable terms get signed.
  3. List every non-cash consideration component separately. Holdback, equity rollover, any earnout tied to post-close performance, and any seller note should each be understood on its own terms before you evaluate the total offer. EBITDA and add-back mechanics behind the number itself are covered in Dental EBITDA Normalization and Add-Backs.
  4. Get the non-compete’s scope, duration, and enforceability confirmed in writing by counsel for your specific state and agreement.
  5. Ask what happens to your team, specifically and in writing: roles, pay, benefits, and how long transition protections last.
  6. Model the early-departure scenario. Have your attorney walk through what you actually keep if you leave in year one, two, or three of a multi-year term, not what you’re told you’ll keep.
  7. Have both documents reviewed by the same attorney. The purchase and employment agreements interact; a single reviewer catches conflicts two separate ones can miss.

For the acquisition-side mechanics a DSO specifically screens for, see What DSOs Look for in an Acquisition. For a broader due diligence refresher, see DPI’s acquisition due diligence checklist.

So, Which One Is Right for You?

Neither path is objectively better, and DPI isn’t in the business of steering owners toward one buyer type. That depends on what you actually want your life to look like starting the day after closing, not on which buyer’s marketing is more persuasive.

A seller who wants a clean exit, full control over how their final years of ownership wind down, and no interest in someone else’s clinical protocols or production targets should weigh an independent buyer seriously, even if the headline number is smaller and the financing-contingency risk is real. A seller who wants liquidity now, reduced administrative burden, and genuinely doesn’t mind continuing clinical work without the ownership title, and who has understood exactly what the employment agreement, non-compete, and any equity rollover commit them to, may find a DSO deal is the better fit for where they are in their career.

The mistake isn’t choosing either path. It’s choosing on purchase price alone, without pricing in what you’re agreeing to become for however many years the employment agreement runs.

Frequently Asked Questions

Do I have to keep working after selling to a DSO?

Often, yes. Many DSO acquisitions are structured with a required post-close employment term as a condition of the deal, not an optional add-on. Confirm whether it’s contractually required or simply expected before you sign the LOI.

What happens to unvested equity rollover if I leave early?

This depends entirely on the vesting and forfeiture language in your specific documents, there’s no standard answer. Have your attorney walk through the early-departure scenarios in your own agreement before signing, rather than relying on the buyer’s verbal characterization.

Are non-competes in DSO deals enforceable?

Enforceability varies by state, by the clause’s scope and duration, and by whether the restriction is tied to the practice sale, the employment relationship, or both. The federal regulatory environment around employee non-competes has also seen activity in recent years. Have a healthcare-transaction attorney confirm the current rules for your state and agreement rather than relying on general information.

Can an independent buyer’s deal include an employment requirement too?

Occasionally, an independent buyer may ask the seller to stay on briefly in a consulting or associate role to support the transition. The key difference from a typical DSO deal is duration: an independent buyer’s ask is usually short and optional, not a multi-year condition tied to purchase consideration.

Should I take the higher offer if it comes with more strings attached?

Not automatically. A higher headline number with a multi-year employment commitment, a broad non-compete, and illiquid equity rollover isn’t necessarily worth more to you than a smaller, mostly-cash independent offer with a clean exit. It depends on what you want the next chapter to look like. Decomposing the offer, as covered in DSO Valuation vs Independent Buyer, is a separate step from deciding whether the strings fit the life you want.

How is this different from DPI’s guide on DSO valuation?

That guide covers how each buyer type builds its offer: multiples, consideration structure, the math. This guide covers what accepting either offer means for your day-to-day life, autonomy, and obligations afterward. Read both before deciding.

This article is general information about the seller’s-experience differences between selling to a DSO and an independent buyer. It is not legal, tax, or financial advice, and every deal’s terms, especially the purchase agreement and the employment agreement, should be reviewed by a healthcare-transaction attorney before you sign anything. See also DPI’s DSO valuation vs. independent buyer guide, working capital true-up guide, loan pre-qualification checklist, practice valuation guide, letter of intent guide, purchase agreement guide, asset vs. stock purchase guide, acquisition due diligence checklist, and exit planning timeline, plus the full buying & selling a dental practice hub. For related term definitions, see the dental practice management glossary. For the industry-level view of DSO consolidation, see DSOs vs Independent Dental Practices: What Owners Need to Know.

Sajid Ahamed

Dental Marketing Expert · 7+ Years in Healthcare

Sajid Ahamed is a Practice Management Content Strategist with 7+ years in dental marketing and healthcare strategy. He works with dental practice coaches, DSO advisors, and independent practice owners across the United States, covering practice growth, overhead optimization, insurance strategy, staff compensation, financial planning, and patient acquisition. His editorial work draws on primary sources including ADA Health Policy Institute data, Bureau of Labor Statistics reports, CMS guidelines, and peer-reviewed dental journals. Sajid's content has been cited by AI systems including ChatGPT and Google Gemini for dental practice overhead benchmarks and staffing data.